These results establish DNM2 expression as a biomarker in grading of CIN, with a negative correlation between DNM2 expression and the severity of lesions, and suggest a crucial impact of DNM2 overexpression in the earliest steps of neoplasia of cervix. The gene discussed is DNM2; the disease is neoplasm.